Reducing Aggression in Military Personnel: A Randomized Clinical Trial

Aim

Evaluate a three-session treatment called Manage Emotions to Reduce Aggression (MERA) to determine whether it reduces frequency of aggression and intensity of anger in active duty military members compared to self-monitoring with risk management and whether those reductions in anger and aggression are maintained over time.

Many of our nation’s warfighters, especially those with posttraumatic stress disorder (PTSD) symptoms, struggle to control anger and aggression, often with devastating interpersonal and societal consequences that can include legal problems, family violence, loss of friends, and even death.

Military personnel with PTSD have higher rates of both anger and aggression compared to military personnel without PTSD. Up to 67% of service members report problems controlling anger after deployment, and anger is a cardinal symptom of PTSD. Additionally, within the first year of returning from deployment, nearly half of combat veterans with PTSD reported engaging in physical aggression.

While the connection among anger, aggression, and PTSD is troubling, research also shows an opportunity to intervene with targeted treatments that help individuals better regulate their emotions. Emotion dysregulation, or the inability to detect, accept, and regulate emotions, is not only related to more aggression and greater PTSD severity but has been shown to precede PTSD symptoms and potentially influence their development. Yet anger and aggression are not specifically targeted in PTSD treatment, and even successful PTSD treatment can still leave residual problems with both.

Offering a solution

In response, Shannon Miles, PhD, and colleagues at James A. Haley Veterans’ Hospital and University of South Florida Morsani College of Medicine developed a brief emotion regulation treatment to help veterans reduce their aggression. Called “Manage Emotions to Reduce Aggression,” or MERA, the treatment involves three sessions and incorporates education, cognitive-behavioral techniques, and acceptance-based skills training.

A previous pilot study by the STRONG STAR Consortium to Alleviate PTSD demonstrated feasibility and promising outcomes, as veterans who completed MERA found it helpful in reducing aggression. Currently, a separate, ongoing randomized clinical trial (RCT) is comparing three sessions of MERA to three sessions of a treatment called Present-Centered Therapy (PCT) in veterans. Preliminary analyses show both MERA and PCT are demonstrating large reductions in aggression after only three sessions.

Evaluating MERA with active duty military personnel

Building on these promising results, Dr. Miles has teamed up with partnering principal investigator Vanessa Jacoby, PhD, ABPP, at The University of Texas at San Antonio Long School of Medicine to lead a STRONG STAR trial at Fort Hood in Killeen, Texas, evaluating MERA’s efficacy with active duty military who have full or subthreshold PTSD.

This trial addresses an important gap in the science, since it is not yet known if active duty service members—who may view anger and aggression positively because it can be adaptive in combat environments—will respond differently to MERA than veterans. Additionally, previous trials with MERA measured emotion dysregulation of all emotions but not specifically anger.

The STRONG STAR trial is a two-sequence, two-period, blinded RCT that will examine the efficacy of MERA as compared to self-monitoring with risk management. Each service member will receive both MERA and self-monitoring with risk management, but the order of the interventions will be randomized. This will allow investigators to test the efficacy of MERA and the sustainability of its effects when service members are switched over to the other treatment.

Ultimately, investigators seek to determine whether MERA successfully reduces frequency of aggression and intensity of anger compared to self-monitoring with risk management and whether those improvements are maintained over time.

Expected results

Investigators believe the study will make positive short- and long-term impacts. In the near term, they expect that service members who engage in MERA will reduce their aggression and anger, which is beneficial to them, their families, their communities, and military operational readiness.

In the long term, they expect to provide the Department of Defense with a brief treatment that will help service members reduce aggression and anger. Because the treatment is only three sessions, they believe service members will be more likely to initiate and complete it compared to longer protocols. Additionally, emotion regulation skills are commonly taught to providers in all mental health training programs. Therefore, MERA has the potential to be quickly disseminated to providers across the military healthcare system.